...
首页> 外文期刊>Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research >Red Cell Distribution Width as an Independent Predictor of Long-Term Mortality in Hip Fracture Patients: A Prospective Cohort Study
【24h】

Red Cell Distribution Width as an Independent Predictor of Long-Term Mortality in Hip Fracture Patients: A Prospective Cohort Study

机译:红细胞分布宽度作为髋部骨折患者长期死亡率的独立预测因素:一项前瞻性队列研究

获取原文
获取原文并翻译 | 示例
           

摘要

Red blood cell distribution width (RDW) has been found to be a significant prognostic factor of mortality in many cardiovascular diseases. However, a link between RDW at admission with long-term mortality in the hip fracture population has not been well established. Therefore, we sought to evaluate the long-term prognostic value of RDW in a well-defined hip fracture cohort, and to compare the effect of RDW in patients with and without anemia. A prospective cohort study was performed on 1479 hip fracture patients admitted at the General Hospital of Chinese PLA between January 2000 and October 2011 with a follow-up study over a 2-year period. A total of 1479 patients were used for the evaluation of 2-year all-cause mortality, while 804 patients with more than 4 years of follow-up were extracted for further evaluation of 4-year all-cause mortality. Cox proportional regression was used to evaluate the association between admission RDW and long-term mortality, adjusting for potential confounding variables. Higher RDW values were strongly associated with increased all-cause mortality. After adjusting for age, mean corpuscular volume, admission hemoglobin, comorbidities, and complications, RDW had a significant independent association with both 2-year mortality with a hazard ratio (HR) of 1.183 (95% confidence interval [ CI], 1.017 to 1.376) and 4-year mortality with an HR of 1.244 (95% CI, 1.052 to 1.471). In stratified analysis, the effect of RDW was even more pronounced, with 2-year mortality HR of 1.341 (95% CI, 1.095 to 1.643) and 4-year mortality HR of 1.345 (95% CI, 1.071 to 1.688) in non-anemic patients. In non-anemic patients, elevated RDW values are significantly associated with increased odds of all-cause mortality, implying that RDW may be a possible laboratory biomarker for risk stratification in non-anemic hip fracture patients. Further studies are needed to confirm the current finding in different and larger hip fracture cohorts. (c) 2015 American Society for Bone and Mineral Research.
机译:在许多心血管疾病中,红细胞分布宽度(RDW)是导致死亡的重要预后因素。但是,入院时RDW与髋部骨折人群的长期死亡率之间的联系尚未得到很好的建立。因此,我们试图评估RDW在明确的髋部骨折队列中的长期预后价值,并比较RDW在有无贫血患者中的作用。在2000年1月至2011年10月间,对中国人民解放军总医院收治的1479例髋部骨折患者进行了一项前瞻性队列研究,并进行了为期2年的随访研究。共有1479名患者被用于评估2年全因死亡率,同时提取了804名随访时间超过4年的患者以进一步评估4年全因死亡率。使用Cox比例回归来评估入院RDW与长期死亡率之间的关联,并调整潜在的混杂变量。较高的RDW值与全因死亡率增加密切相关。调整年龄,平均红细胞体积,入院血红蛋白,合并症和并发症后,RDW与两年死亡率均具有显着的独立关联,危险比(HR)为1.183(95%置信区间[CI],1.017至1.376) )和4年死亡率,HR为1.244(95%CI,1.052至1.471)。在分层分析中,RDW的影响更为显着,在非糖尿病患者中,两年死亡率HR为1.341(95%CI,1.095至1.643),四年死亡率HR为1.345(95%CI,1.071至1.688)。贫血的患者。在非贫血患者中,RDW值升高与全因死亡率增加的可能性显着相关,这意味着RDW可能是非贫血性髋部骨折患者危险分层的实验室生物标志物。需要进一步的研究来证实在不同和更大的髋部骨折队列中的当前发现。 (c)2015年美国骨与矿物质研究学会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号